Virus diseases.
D000547:Amantadine / Q000627:therapeutic use; D002644:Chickenpox / Q000188:drug therapy; D003561:Cytarabine / Q000627:therapeutic use; D003587:Cytomegalovirus; D004267:DNA Viruses; D005128:Eye Diseases / Q000188:drug therapy; D005260:Female; D005832:Genital Diseases, Male; D005892:Gingivitis, Necrotizing Ulcerative / Q000188:drug therapy; D006562:Herpes Zoster / Q000188:drug therapy; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007251:Influenza, Human / Q000188:drug therapy; D008297:Male; D009262:Nails / Q000473:pathology; D010406:Penicillins / Q000627:therapeutic use; D011213:Poxviridae Infections / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000209:etiology; D018139:Simplexvirus; D013290:Streptococcal Infections / Q000188:drug therapy; D013882:Thiosemicarbazones / Q000627:therapeutic use; D014570:Urologic Diseases / Q000188:drug therapy; D014611:Vaccination; D014777:Virus Diseases / Q000188:drug therapy* / Q000517:prevention & control
D010406:Penicillins; D013882:Thiosemicarbazones; D003561:Cytarabine; D000547:Amantadine; D007065:Idoxuridine